Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract CT271: Translational analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)

Anthony W. Tolcher, Timothy A. Yap, Ruth Plummer, Thomas Grombacher, Danyi Wang, Corinna Schaffroth, Christine Hicking, Zoltan Szucs, Giuseppe Locatelli, Johann S. de Bono

Cancer Res (2023) 83 (8_Supplement): CT271.

https://doi.org/10.1158/1538-7445.AM2023-CT271

Published: 14 April 2023

View article titled, Abstract CT271: Translational analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)

Journal Articles

Abstract 2588: M1774, a novel potent and selective ATR inhibitor, shows antitumor effects as monotherapy and in combination

Astrid Zimmermann, Heike Dahmen, Thomas Grombacher, Ulrich Pehl, Andree Blaukat, Frank T. Zenke

Cancer Res (2022) 82 (12_Supplement): 2588.

https://doi.org/10.1158/1538-7445.AM2022-2588

Published: 15 June 2022

View article titled, Abstract 2588: M1774, a novel potent and selective ATR inhibitor, shows antitumor effects as monotherapy and in combination

Journal Articles

Abstract 338: A new investigational ATM Inhibitor, M3541, synergistically potentiates fractionated radiotherapy and chemotherapy in cancer cells and animal models

Astrid Zimmermann, Frank Zenke, Heike Dahmen, Christian Sirrenberg, Thomas Grombacher, Lyubomir T. Vassilev, Thomas Fuchss, Andree Blaukat

Cancer Res (2018) 78 (13_Supplement): 338.

https://doi.org/10.1158/1538-7445.AM2018-338

Published: 01 July 2018

View article titled, Abstract 338: A new investigational ATM Inhibitor, M3541, synergistically potentiates fractionated radiotherapy and chemotherapy in cancer cells and animal models

Journal Articles

Abstract 4183: A novel selective DNA-PK inhibitor, M3814, as a potential combination partner of Etoposide and Cisplatin in the therapy of lung cancer

Christian Sirrenberg, Astrid Zimmermann, Thomas Grombacher, Lyubomir T. Vassilev, Lars Damstrup, Frank T. Zenke, Andree Blaukat

Cancer Res (2017) 77 (13_Supplement): 4183.

https://doi.org/10.1158/1538-7445.AM2017-4183

Published: 01 July 2017

View article titled, Abstract 4183: A novel selective DNA-PK inhibitor, M3814, as a potential combination partner of Etoposide and Cisplatin in the therapy of lung cancer

Journal Articles

Regulation of Expression of the DNA Repair Gene O⁶-Methylguanine-DNA Methyltransferase via Protein Kinase C-mediated Signaling

Istvan Boldogh, Chilakamarti V. Ramana, Zhenping Chen, Tapan Biswas, Tapas K. Hazra, Sabine Grösch, Thomas Grombacher, Sankar Mitra, Bernd Kaina

Cancer Res (1998) 58 (17): 3950–3956.

Published: 01 September 1998

View article titled, Regulation of Expression of the DNA Repair Gene <em>O</em><sup>6</sup>-Methylguanine-DNA Methyltransferase via Protein Kinase C-mediated Signaling

NARROW

Abstract CT271: Translational analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)

Abstract 2588: M1774, a novel potent and selective ATR inhibitor, shows antitumor effects as monotherapy and in combination

Abstract 338: A new investigational ATM Inhibitor, M3541, synergistically potentiates fractionated radiotherapy and chemotherapy in cancer cells and animal models

Abstract 4183: A novel selective DNA-PK inhibitor, M3814, as a potential combination partner of Etoposide and Cisplatin in the therapy of lung cancer

Regulation of Expression of the DNA Repair Gene O⁶-Methylguanine-DNA Methyltransferase via Protein Kinase C-mediated Signaling

Email alerts

AACR Journals

Abstract CT271: Translational analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)

Abstract 2588: M1774, a novel potent and selective ATR inhibitor, shows antitumor effects as monotherapy and in combination

Abstract 338: A new investigational ATM Inhibitor, M3541, synergistically potentiates fractionated radiotherapy and chemotherapy in cancer cells and animal models

Abstract 4183: A novel selective DNA-PK inhibitor, M3814, as a potential combination partner of Etoposide and Cisplatin in the therapy of lung cancer

Regulation of Expression of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase via Protein Kinase C-mediated Signaling

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Regulation of Expression of the DNA Repair Gene O⁶-Methylguanine-DNA Methyltransferase via Protein Kinase C-mediated Signaling